[1]Emens LA.Breast cancer immunotherapy:Facts and hopes[J].Clinical Cancer Research,2018,24(3):3001.
[2]Andersson Y,Frisell J,Sylvan M.Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes[J].Breast Cancer Research & Treatment,2018,171(2):359-369.
[3]Dent R,Trudeau M,Pritchard KI.Triple-negative breast cancer:Clinical features and patterns of recurrence[J].Clinical Cancer Research,2018,13(15 Pt 1):4429-4434.
[4]Brisson L,Gillet L,Antelmi E.NaV1.5 enhances breast cancer cell invasiveness by increasing NHE1-dependent H+ efflux in caveolin-rich microdomains[J].Oncogene,2018,30(17):2070-2076.
[5]Luctkarflude M,Aiken A,Mccoll MA.What do primary care providers think about implementing breast cancer survivorship care[J]?Current Oncology,2018,25(3):196-205.
[6]Irnaten M,Zhdanov A,Brennan D.Activation of the NFAT-calcium signaling pathway in human lamina cribrosa cells in glaucoma[J].Invest Ophthalmol Vis Sci,2018,59(2):831-842.
[7]Lu WC,Xie H,Tie XX.NFAT-1 hyper-activation by methionine enkephalin (MENK) significantly induces cell apoptosis of rats C6 glioma in vivo,and in vitro[J].International Immunopharmacology,2018(56):1-8.
[8]He RL,Wu ZJ,Liu XR.Calcineurin/NFAT signaling modulates pulmonary artery smooth muscle cell proliferation,migration and apoptosis in monocrotaline-induced pulmonary arterial hypertension rats[J].Cellular Physiology & Biochemistry,2018,49(1):172.
[9]Müller MR,Rao A.NFAT,immunity and cancer:A transcription factor comes of age[J].Nature Reviews Immunology,2010,10(9):645.
[10]Ouyang Z,Guo X,Chen X.Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway[J].Oncotarget,2018,9(2):1868.
[11]Dent R,Trudeau M,Pritchard KI.Triple-negative breast cancer:Clinical features and patterns of recurrence[J].Clinical Cancer Research,2018,13(15 Pt 1):4429-4434.
[12]D' Souza V,Daudt H,Kazanjian A.Survivorship care plans for breast cancer patients:Understanding the quality of the available evidence[J].Current Oncology,2017,24(6):e446.
[13]Duffy MJ,Harbeck N,Nap M.Clinical use of biomarkers in breast cancer:Updated guidelines from the European Group on Tumor Markers (EGTM)[J].European Journal of Cancer,2017,75(1):284-298.
[14]Mulder RL,Kremer LCM,Hudson MM.Recommendations for breast cancer surveillance for female survivors of childhood,adolescent,and young adult cancer given chest radiation:A report from the international late effects of childhood cancer guideline harmonization group[J].Lancet Oncology,2017,18(2):e75.
[15]Basant A,Glotzer M.Spatiotemporal regulation of RhoA during cytokinesis[J].Current Biology,2018,28(9):R570-R580.
[16]Matsukawa T,Morita K,Omizu S.Mechanisms of RhoA inactivation and CDC42 and Rac1 activation during zebrafish optic nerve regeneration[J].Neurochemistry International,2018(112):71-80.
[17]Herbert LM,Resta TC,Jernigan NL.RhoA Increases ASIC1a plasma membrane localization and calcium influx in pulmonary arterial smooth muscle cells following chronic hypoxia[J].Am J Physiol Cell Physiol,2018:00159.
[18]Zhang S,Tang Q,Xu F.RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors[J].Molecular Cancer Research Mcr,2009,7(4):570.
[19]Li X,Liu J,Chen B.A positive feedback loop of Profilin-1 and RhoA/ROCK1 promotes endothelial dysfunction and oxidative stress[J].Oxidative Medicine & Cellular Longevity,2018,23(12):2015.
[20]Liang J,Zeng X,Halifu Y.Blocking RhoA/ROCK inhibits the pathogenesis of pemphigus vulgaris by suppressing oxidative stress and apoptosis through TAK1/NOD2-mediated NF-κB pathway[J].Molecular & Cellular Biochemistry,2017,436(1-2):1-8.
[21]Sun K,Duan X,Cai H.Curcumin inhibits LPA-induced invasion by attenuating RhoA/ROCK/MMPs pathway in MCF7 breast cancer cells[J].Clinical & Experimental Medicine,2016,16(1):37-47.
[22]Zhang C,Wang HJ,Bao QC.NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction[J].Oncotarget,2016,7(45):73593.
[23]Kim YN,Choe SR,Cho KH.Resveratrol suppresses breast cancer cell invasion by inactivating a RhoA/YAP signaling axis[J].Experimental & Molecular Medicine,2017,49(2):e296.
[24]Liu Q,Wang W,Yang X.MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer[J].Oncology Reports,2016,36(1):189-196.
[25]Xu W,Gu J,Ren Q.NFATC1 promotes cell growth and tumorigenesis in ovarian cancer up-regulating c-Myc through ERK1/2/p38 MAPK signal pathway[J].Tumor Biology,2016,37(4):4493-4500.
[26]Wang L,Wang Z,Li J.NFATc1 activation promotes the invasion of U251 human glioblastoma multiforme cells through COX-2[J].International Journal of Molecular Medicine,2015,35(5):1333-1340.